Zafgen (ZFGN) PT Cut to $46 at Leerink Partners Amid Partial Clinical Hold; Maintains Bullish View
Tweet Send to a Friend
Leerink Partners analyst Joseph Schwartz lowered his price target on Zafgen (NASDAQ: ZFGN) to $46.00 (from $56.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
